Management report as at 30 September 2020
Notes to the individual financial report as at 30 September 2020
Individual financial report according to IFRS as at 30 September 2020
Sales revenues for September 2020
Sofia, Bulgaria, October 5, 2020 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for September 2020 the Company recorded a decrease in sales of 14% compared to the same month of 2019, incl. 10% increase in domestic sales and 29% decrease in export sales.
Notification from Donev Investments Holding AD under Art. 19 of Regulation (EU) No 596/2014 of September 30, 2020.
Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of September 30, 2020.
Notification from Donev Investments Holding AD under Art. 19 of Regulation (EU) No 596/2014 of September 29, 2020.
Notification for acquisition of own shares
Sofia, Bulgaria, September 30, 2020 - According to art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on September 29, 2020 the Company bought 65 000 own shares representing 0.0482% of the share capital of the Company, at a total value of BGN 200 200 on the Bulgarian Stock Exchange, the average price per share was 3.0800 BGN.
The total number of treasury shares after this transaction is 9 011 467, representing 6.685% of the share capital of the Company.